IP Library Granted Patent US 9,353,408
Granted Patent B2
US 9,353,408 · App. 14/825,364 · Granted May 31, 2016

Dynamic flux nucleic acid sequence amplification

Inventor: Brian Erich Caplin (Park City, UT)
Assignee: Fluoresentric, Inc.
C12Q1/6844C12Q1/689C12Q1/6827C12Q1/6846C12Q1/6886C12Q1/703C12Q2600/106
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,353,408
App. No.
14/825,364
Granted
May 31, 2016
Kind
B2
Abstract

Provided herein are dynamic flux nucleic acid sequence amplification methods. The dynamic flux nucleic acid sequence amplification methods described herein are capable of amplifying nucleic acid sequences within a narrow temperature range. In some aspects, the disclosure provides for real-time dynamic flux nucleic acid sequence amplification methods.

Claims (23)

1. A real-time dynamic flux method of nucleic acid sequence amplification, comprising:

a. combining a pair of forward and reverse oligonucleotide primers with a target nucleic acid sequence to be amplified; and

b. amplifying the target nucleic acid sequence by thermocycling the pair of forward and reverse oligonucleotide primers and the target nucleic acid sequence within a 15° C. temperature range that is defined by the area contained within the overlap of an annealing curve (T A ) of the pair of oligonucleotide primers and the denaturation curve (T D ) of the target nucleic acid sequence,

wherein each forward and reverse oligonucleotide primer has a melting temperature (T m ) within 15° C. of the T m of the target nucleic acid sequence, and

wherein thermocycling comprises:

i. denaturing the target nucleic acid sequence; and

ii. annealing of the forward and reverse oligonucleotide primers; and

iii. extension of the target nucleic acid sequence by the forward and reverse oligonucleotide primers,

c. simultaneously detecting the amplified target nucleic acid sequence during said amplifying step.

2. The real-time dynamic flux method of nucleic acid sequence amplification of claim 1 , wherein detecting occurs by monitoring fluorescence.

3. The real-time dynamic flux method of nucleic acid sequence amplification of claim 1 , wherein detecting occurs by monitoring fluorescence of a fluorescent dye that intercalates with double-stranded DNA.

4. The real-time dynamic flux method of nucleic acid sequence amplification of claim 1 , wherein detecting occurs by monitoring fluorescence of a sequence-specific oligonucleotide probe labelled with a fluorescent reporter.

5. The real-time dynamic flux method of nucleic acid sequence amplification of claim 1 , wherein amplifying the target nucleic acid sequence by thermocycling the pair of forward and reverse oligonucleotide primers and the target nucleic acid sequence occurs within a 10° C. temperature range.

6. The real-time dynamic flux method of nucleic acid sequence amplification of claim 1 , wherein amplifying the target nucleic acid sequence by thermocycling the pair of forward and reverse oligonucleotide primers and the target nucleic acid sequence occurs within a 5° C. temperature range.

7. The real-time dynamic flux method of nucleic acid sequence amplification of claim 1 , wherein amplifying the target nucleic acid sequence by thermocycling the pair of forward and reverse oligonucleotide primers and the target nucleic acid sequence occurs within a 2.5° C. temperature range.

8. The real-time dynamic flux method of nucleic acid sequence amplification of claim 1 , wherein amplifying the target nucleic acid sequence by thermocycling the pair of forward and reverse oligonucleotide primers and the target nucleic acid sequence occurs within a 2.5° C. to 10° C. temperature range around the melting temperature of the target nucleic acid sequence.

9. The real-time dynamic flux method of nucleic acid sequence amplification of claim 1 , wherein one of the pair of oligonucleotide primers has a greater melting temperature range difference with the melting temperature of the target nucleic acid sequence than the second of the pair of oligonucleotide primers.

10. The real-time dynamic flux method of nucleic acid sequence amplification of claim 1 , wherein the melting temperature of one of the oligonucleotide primers is the same as the melting temperature of the target nucleic acid sequence.

11. The real-time dynamic flux method of nucleic acid sequence amplification of claim 1 , wherein the melting temperature of at least one of the oligonucleotide primers is within 10° C. of the melting temperature of the target nucleic acid sequence.

12. The real-time dynamic flux method of nucleic acid sequence amplification of claim 1 , wherein the melting temperature of at least one of the oligonucleotide primers is within 5° C. of the melting temperature of the target nucleic acid sequence.

13. The real-time dynamic flux method of nucleic acid sequence amplification of claim 1 , wherein the melting temperature of at least one of the oligonucleotide primers is within 2.5° C. of the melting temperature of the target nucleic acid sequence.

14. The real-time dynamic flux method of nucleic acid sequence amplification of claim 1 , wherein each of the pair of oligonucleotide primers is present in an approximately equimolar concentration.

15. The real-time dynamic flux method of nucleic acid sequence amplification of claim 1 , further comprising: adjusting the pH of the amplification reaction to increase the specificity of selectively amplifying the target nucleic acid over other nucleic acids.

Assignments (4)
CORRECTIVE ASSIGNMENT TO CORRECT THE THE RECEIVING PARTY NAME PREVIOUSLY RECORDED AT REEL: 055828 FRAME: 0971. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Feb 13, 2023
From: FLUORESENTRIC, INC.
To: XCR DIAGNOSTICS, INC.
Reel/Frame 063601/0176 →
MERGER Recorded Apr 5, 2021
From: FLUORESENTRIC, INC.
To: XCR DIAGNOSTIC, INC.
Reel/Frame 055828/0971 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 29, 2017
From: CAPLIN, BRIAN ERICH
To: SIGNAL DIAGNOSTICS, INC.
Reel/Frame 044507/0265 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 25, 2015
From: SIGNAL DIAGNOSTICS, INC.
To: FLUORESENTRIC, INC.
Reel/Frame 036656/0364 →
Continuity (4)
Continuation 12951710 · Nov 22, 2010
Continuation 12058637 · Mar 28, 2008
Provisional Application 60908604 · Mar 28, 2007
Related Publication 20150376689A1 · Dec 31, 2015